ArticleJournal of clinical pharmacology2025

Clinical Evaluation of Drug-Drug Interactions Between Bictegravir and Strong Inhibitors/Inducers of the CYP3A4, UGT1A1, or P-gp Pathways.

Priyanka Arora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.